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1.	Supplementary	figures.	
	
	
	
Figure	 S1.	MALDI-TOFF	 spectrum	 of	 the	 crude	 reaction	 mixture	 of	 the	 attempted	synthesis	 of	 compound	 1e,	 showing	 the	 presence	 of	 oligomeric	 BODIPYs	 with	ciclohexane-1,1-dicarboxylate	bridges	between	units	(see	structure	below;	the	arrows	mark	the	number	of	monomeric	BODIPYs	in	the	oligomers,	which	appear	in	pairs	with	different	X	terminal	groups).	
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Figure S2. Sketch of cavity/pump configurations used throughout the paper: a) plane-
parallel full cavity (2 cm), b) cuvette cavity (1 cm), b) cuvette cavity, c) Triangular quartz 
cell, d) front-face configuration, and e) tuning cavity. 
	
Figure S3. Normalized Laser Induced Fluorescence (LIF) spectra of dye 1b at different 
concentrations and pump energies. 
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Figure S4. Normalized absorption and fluorescence spectra of dye 1b (A) and 2b (B) in 
diluted (1 cm optical path length) and concentrated (0.001 cm optical path length) solutions 
in ethyl acetate. Normalized fluorescence spectra after reabsorption correction at high 
concentration (C and D, respectively). 
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Figure S5. Normalized absorption and fluorescence spectra of 2b (10 µM) in water-ethanol 
mixtures to demonstrate that the spectral shape does not change. In water-rich mixtures, the 
sample is no longer a “true” solution and becomes a colloidal suspension. For this reason, 
the baseline correction is not good enough in such mixtures. 
 
 
Figure S6. Absorption and fluorescence spectra of dye 1b in water-ethanol mixtures (10 
µM dye concentration).  
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Figure S7. Fluorescence decay curves of 1b in water-ethanol mixture (90:10 v/v) with a 10 
µM dye concentration, exciting at 470 nm and monitoring the emission in both peaks: 510 
nm for the monomer and 550 nm for the J-aggregate. 
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2.	General	experimental	procedures	and	synthesis	of	B-spiranic	O-
BODIPYs	
 
General. All melting points were measured with a Reicher Jung Thermovar micro-melting 
apparatus. Proton and carbon-13 nuclear magnetic resonance (1H NMR or 13C NMR) 
spectra were recorded on a Varian INOVA 400 (400 and 100 MHz, respectively) or a 
Varian UNITY 500 (500 and 125 MHz, respectively) spectrometers. Chemical shifts are 
expressed in parts per million (δ scale) downfield from tetramethylsilane and are referenced 
to residual peaks of the deuterated NMR solvent used or to internal tetramethylsilane. Data 
are presented as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, m 
= multiplet and/or multiple resonances, b = broad), integration, coupling constants in hertz 
(Hz), and assignment. Proton and carbon-13 assignments are based on DQ-COSY, HSQC, 
and HMBC correlation experiments. Thin layer chromatography (TLC) was performed 
with Merck Silica Gel 60 F254 plates. Chromatograms were visualized using UV light (254 
nm or 365 nm) and/or treatment with a solution of ammonium molybdate (50 g) and 
cerium(IV) sulphate (1 g) in 5 % aqueous H2SO4 (1 L) followed by charring on a hot plate. 
Column chromatography was performed on a 971-FP Flash Purification System from 
Agilent Tecnologies using SF Si35 silica cartridges. Mass spectra of oligomers were 
recorded on a MALDI Voyager-DE PRO time-of-flight (TOF) spectrometer (Applied 
Biosystems), using a 2,5-dihydroxybenzoic acid matrix. High-resolution mass spectra 
(HRMS) were recorded on an Agilent 6520 Q-TOF instrument with an ESI source.  
Anhydrous solvents were prepared according to standard methods by distillation 
over drying agents or via elution through a PureSolv™ column drying system from 
Innovative Technology, Inc. All other solvents were of HPLC grade and were used as 
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provided. All reactions were carried out with magnetic stirring and, if air or moisture 
sensitive, in oven-dried glassware under argon. Microwave irradiation experiments were 
performed with a single-mode Discover System from CEM Corporation, using standard 
Pyrex tubes (10 or 35 mL capacity) sealed with a rubber cap.  
General method for the synthesis of O-BODIPYs by reaction of F-BODIPYs with 
diacids or hydroxyacids. A solution of the starting F-BODIPY (0.11 mmol), the diacid or 
hydroxyacid (0.13 mmol), and trimethylsilyl chloride (2.2 mmol) in dry MeCN (4 mL) was 
heated under microwave irradiation at 120 ºC for 30 minutes. The solvent and excess 
volatile reagents were removed at reduced pressure and the crude product was purified by 
flash column chromatography (hexane/EtOAc) or by crystallization.  
Photophysical properties. The absorption and fluorescence spectra, as well as 
fluorescence decay curves, were measured in diluted solutions (around 2×10–6 M) and 
concentrated solutions (up to 10–2 M) of ethyl acetate using quartz cuvettes of different 
pathway (from 1 cm to 0.01 cm or 0.001 cm, respectively). The water rich mixtures with 
ethanol were stirred during the measure to avoid flocculation of the suspension. UV-Vis 
absorption and fluorescence spectra were recorded on a Varian model CARY 4E 
spectrophotometer and on an Edinburgh Instruments spectrofluorimeter (model FLSP 920), 
respectively. The fluorescence spectra of diluted samples were measured in right-angle, 
whereas concentrated ones in front-face to minimize inner filter effects. Fluorescence 
quantum yields (φ) were obtained using PM546 (φr = 0.85 in ethanol)[1] as reference, with 
the exception of 3a, in which PM567 (φr = 0.84 in ethanol)[1] were employed. These 
fluorescence efficiencies were calculated from corrected spectra (detector sensibility to the 
wavelength) and corrected by the refractive index of the solvent. Radiative decay curves 
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were registered with the time correlated single-photon counting technique (Edinburgh 
Instruments, model FL900, with picosecond time-resolution). Fluorescence emission was 
monitored at the maximum emission wavelength after excitation at 470 nm by means of a 
diode laser (PicoQuant LDH470) with a repetition rate of 10 MHz. The fluorescence 
lifetime (τ) was obtained from the slope of an exponential fit after the deconvolution of the 
instrumental response signal from the recorded decay curves by means of an iterative 
method. The goodness of the exponential fit was controlled by statistical parameters (chi-
square, Durbin-Watson and the analysis of the residuals). 
Fluorescence images in the solid state were recorded with an optical inverted microscope 
with epi configuration (Olympus BX51) equipped with a color CCD camera (DP72, 
Olympus). Crystals were excited under blue light by Chroma band pass filters (D470/40) 
and the emission was collected with Chroma cut-off filters (E515LPv2). The corresponding 
spectra were registered coupling the microscope to the aforementioned spectrofluorimeter 
by an optical fiber. Absolute fluorescence quantum yields were measured by means of an 
integrated sphere coupled to the spectrofluorimeter. 
Atomistic simulation. The generic DREIDING force field[2] was used to model the short-
range and van der Waals interactions, while the long-range interactions were computed by a 
coulombic potential. The atomic charges were obtained from Density Functional Theory 
(DFT) simulations as implemented in the Gaussian09[3] using the B3LYP exchange 
correlation functional and a 6-311G+ basis set. The internal structure of the dyes were 
relaxed to a local minimum of energy, and the charges were computed under the ChelpG 
scheme.[4] Molecular Dynamics simulations were carried out using the LAMMPS package 
(05Sep14 version)[5] in the NPT ensemble at room temperature and pressure conditions. 
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The calculations were done using the Nose-Hoover style equations of motions derived by 
Shinoba et al.,[6] with a timestep of 1fs and thermostating and barostating constants of 100 
and 1000 fs respectively. The long range interactions were computed using the particle-
particle particle-mesh method.[7] The solvent boxes were prepared placing randomly the 
desired number of molecules with Packmol,[8] and probability analyses of the trayectories 
were done using Travis.[9]  
Lasing properties. Liquid solutions of dyes were contained in 1 cm optical-path 
rectangular quartz cells carefully sealed to avoid solvent evaporation during experiments. 
The liquid solutions were transversely pumped at 355 nm, with 5 mJ, 8 ns FWHM pulses 
from the third-harmonic of Q-switched Nd:YAG laser (Spectron SL282G), at a repetition 
rate of up to 10 Hz. The exciting pulses were line-focused onto the cell, providing pump 
fluences on the active medium in the range 110 - 180 mJ/cm2. The oscillation cavity (2 cm 
length) consisted of a 90% reflectivity aluminum mirror, with the lateral face of the cell as 
output coupler. Narrow-linewidth laser emission and tuning ranges of dye solutions were 
obtained by placing the samples in a home-made Shoshan-type oscillator (Figure S2e) 
consisting of full-reflecting aluminium back and tuning mirrors, and a 2400 lines mm–1 
holographic grating in grazing incidence, with outcoupling via the grating zero order.[10] 
Wavelength tuning was accomplished by rotation of the tuning mirror. Tuning mirror and 
grating (both from Optometrics) were 5 cm wide and the angle of incidence on the grating 
was 88.5°. Laser linewidth was measured with a Fabry-Perot etalon (IC Optical Systems) 
with a free spectral range of 15.9 GHz. 
X-ray diffraction studies. Intensity data were collected on an Agilent Technologies Super-
Nova diffractometer, wich was equipped with monochromated Cu kα radiation (λ= 1.54184 
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Å) and Atlas CCD detector. Measurement was carried out at 99.99(10) K with the help of 
an Oxford Cryostream 700 PLUS temperature device. Data frames were processed (united 
cell determination, analytical absorption correction with face indexing, intensity data 
integration and correction for Lorentz and polarization effects) using the Crysalis software 
package.[11] The structure was solved using Olex2[12] and refined by full-matrix least-
squares with SHELXL-97.[13] Final geometrical calculations were carried out with 
Mercury[14] and PLATON[15] as integrated in WinGX.[16] Crystallographic data (excluding 
structure factors) for the structure(s) reported in this paper have been deposited with the 
Cambridge Crystallographic Data Centre as supplementary publication no. CCDC-	
1411347-1411349 and CCDC-1411353-1411358. Copies of the data can be obtained free 
of charge from www.ccdc.cam.ac.uk/conts/retrieving.html. 
Synthesis of O-BODIPY 1a. Reaction of F-BODIPY 1 (30 mg, 0.082 mmol) with malonic 
acid (9 mg, 0.086 mmol) following the general method for the synthesis of O-BODIPYs 
gave 1a (33 mg, 94%) as a dark-red solid, after flash chromatography purification 
(hexane/EtOAc 76:24 → 41:59). 
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Mp 115-118 ºC. ¹H NMR (CDCl3, 500 MHz): δ = 1.39 (s, 6H, CH3-C1, CH3-C7), 2.09 (s, 
6H, CH3-C2', CH3-C6'), 2.31 (s, 6H, CH3-C3, CH3-C5), 2.34 (s, 3H, CH3-C4'), 3.65 (s, 2H, 
C2"H2), 5.99 (s, 2H, C2H, C6H), 6.96 (s, 2H, C3'H, C5'H). ¹³C NMR (CDCl3, 125 MHz): δ 
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= 13.8 (CH3-C1, CH3-C7), 15.1 (CH3-C3, CH3-C5), 19.7 (CH3-C2', CH3-C6'), 21.4 (CH3-
C4'), 37.9 (C2''), 122.5 (C2, C6), 129.4 (C3', C5'), 130.6 (C1'), 131.5 (C1,C7), 134.8 (C2', 
C6'), 139.2 (C4'), 143.0 (C8), 144.0 (C9a, C9b), 154.4 (C3, C5), 166.8 (2×C=O). HRMS 
(API-ES+): calcd for C25H28BN2O4 (M+H)+: 431.2142, found: 431.2147. 
Synthesis of O-BODIPY 1b. Reaction of F-BODIPY 1 (37 mg, 0.101 mmol) with 
cyclopropane-1,1-dicarboxylic acid (15 mg, 0.115 mmol) following the general method for 
the synthesis of O-BODIPYs gave 1b (39 mg, 85%) as a dark-red solid, after flash 
chromatography purification (hexane/EtOAc 100:0 → 80:20). 
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Mp 242-245 ºC. ¹H NMR (CDCl3, 500 MHz): δ = 1.39 (s, 6H, CH3-C1, CH3-C7), 1.93 (s, 
4H, C3''H2, C4''H2), 2.09 (s, 6H, CH3-C2', CH3-C6'), 2.34 (s, 3H, CH3-C4'), 2.37 (s, 6H, 
CH3-C3, CH3-C5), 5.99 (s, 2H, C2H, C6H), 6.96 (s, 2H, C3'H, C5'H). ¹³C NMR (CDCl3, 
125 MHz): δ = 13.7 (CH3-C1, CH3-C7), 15.1 (CH3-C3, CH3-C5), 19.7 (CH3-C2', CH3-C6'), 
21.4 (CH3-C4'), 23.8 (C3'', C4''), 25.6 (C2''), 122.3 (C2, C6), 129.3 (C3', C5'), 130.8 (C1'), 
131.4 (C1, C7), 134.9 (C2', C6'), 139.1 (C4'), 142.7 (C8), 143.7 (C9a, C9b), 154.7 (C3, 
C5), 171.0 (2×C=O). HRMS (API-ES+): calcd. for C27H30BN2O4 (M+H)+: 457.2298, found: 
457.2299. 
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Synthesis of O-BODIPY 1c. Reaction of F-BODIPY 1 (40 mg, 0.109 mmol) with 
cyclobutane-1,1-dicarboxylic acid (21 mg, 0.146 mmol) following the general method for 
the synthesis of O-BODIPYs gave 1c (50 mg, 98%) as a dark-red solid, after flash 
chromatography purification (hexane/EtOAc 100:0 → 50:50). 
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Mp. 253-255 ºC. ¹H NMR (CDCl3, 400 MHz): δ = 1.37 (s, 6H, CH3-C1, CH3-C7), 2.07 (s, 
6H, CH3-C2', CH3-C6'), 2.19 (s, 6H, CH3-C3, CH3-C5), 2.33 (s, 3H, CH3-C4'), 2.42 (m, 
2H, C4''H2), 2.78 (m, 4H, C3''H2, C5''H2), 5.95 (s, 2H, C2H, C6H), 6.95 (s, 2H, C3'H, 
C5'H). ¹³C NMR (CDCl3, 100 MHz): δ = 13.7 (CH3-C1, CH3-C7), 15.2 (CH3-C3, CH3-C5), 
16.4 (C4''), 19.7 (CH3-C2', CH3-C6'), 21.4 (CH3-C4'), 31.4 (C3'', C5''), 47.5 (C2''), 122.3 
(C2, C6), 129.3 (C3', C5'), 130.7 (C1'), 131.4 (C1, C7), 134.9 (C2', C6'), 139.1 (C4'), 142.8 
(C8), 143.6 (C9a, C9b), 154.3 (C3, C5), 174.6 (2×C=O). HRMS (API-ES+): calcd. for 
C28H32BN2O4 (M+H)+: 471.2455, found: 471.2445. 
Synthesis of O-BODIPY 1d. Reaction of F-BODIPY 1 (40 mg, 0.109 mmol) with 
cyclopentane-1,1-dicarboxylic acid (22 mg, 0.139 mmol) following the general method for 
the synthesis of O-BODIPYs (microwave irradiation time = 45 min) gave 1d (39 mg, 74%) 
as a dark-red solid, after recrystallization of the crude evaporated reaction mixture from 
MeCN at 5 ºC. 
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Mp. 267-270 ºC. ¹H NMR (CDCl3, 500 MHz): δ = 1.37 (s, 6H,CH3-C1, CH3-C7), 2.04 (m, 
4H, CH3-C4'', CH3-C5''), 2.08 (s, 6H, CH3-C2', CH3-C6'), 2.33 (s, 3H, CH3-C4'), 2.35 (s, 
3H, CH3-C3, CH3-C5), 2.39 (m, 4H, C3''H2, C6''H2), 5.96 (s, 2H, C2H, C6H), 6.96 (s, 2H, 
C3'H, C5'H). ¹³C NMR (CDCl3, 125 MHz): δ = 13.8 (CH3-C1, CH3-C7), 16.1 (CH3-C3, 
CH3-C5), 19.7 (CH3-C2', CH3-C6'), 21.4 (CH3-C4'), 28.6 (C4'', C5''), 42.1 (C3'', C6''), 54.6 
(C2''), 122.4 (C2, C6), 129.3 (C3', C5'), 130.8 (C1'), 131.6 (C1, C7), 134.9 (C2', C6'), 139.1 
(C4'), 142.7 (C8), 143.7 (C9a, C9b), 154.6 (C3, C5), 176.8 (2×C=O). HRMS (API-ES+): 
calcd. for C29H34BN2O4 (M+H)+: 485.2612, found: 485.2588. 
Synthesis of O-BODIPY 1g. Reaction of F-BODIPY 1 (30 mg, 0.082 mmol) with oxalic 
acid (8 mg, 0.089 mmol) following the general method for the synthesis of O-BODIPYs 
gave 1g (33 mg, 97%) as a dark-red solid, after flash chromatography purification 
(hexane/EtOAc 94:6 → 70:30). 
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Mp. 205-207 ºC. ¹H NMR (CDCl3, 500 MHz): δ = 1.42 (s, 6H, CH3-C1, CH3-C7), 2.10 (s, 
6H, CH3-C2', CH3-C6'), 2.30 (s, 6H, CH3-C3, CH3-C5), 2.35 (s, 3H, CH3-C4'), 6.03 (s, 2H, 
C2H, C6H), 6.99 (s, 2H, C3'H, C5'H). ¹³C NMR (CDCl3, 125 MHz): δ = 13.8 (CH3-C1, 
CH3-C7), 15.7 (CH3-C3, CH3-C5), 19.7 (CH3-C2', CH3-C6'), 21.4 (CH3-C4'), 123.2 (C2, 
C6), 129.5 (C3',C5’), 130.3 (C1'), 131.9 (C1, C7), 134.7 (C2', C6'), 139.4 (C4'), 143.2 (C8), 
145.1 (C9a, C9b), 155.8 (C3, C5), 159.9 (2×C=O). HRMS (API-ES+): calcd. for 
C24H26BN2O4 (M+H)+: 417.1986, found: 417.1975. 
Synthesis of O-BODIPY 1h. Reaction of F-BODIPY 1 (35 mg, 0.096 mmol) with salicilic 
acid (15 mg, 0.109 mmol) following the general method for the synthesis of O-BODIPYs 
gave 1h (39 mg, 87%) as a dark-red solid, after flash chromatography purification 
(hexane/EtOAc 100:0 → 80:20). 
N B N
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Mp. 278-280 ºC. ¹H NMR (CDCl3, 500 MHz): δ = 1.39 (s, 6H, CH3-C1, CH3-C7), 2.12 (s, 
3H, CH3-C6'), 2.13 (s, 6H, CH3-C3, CH3-C5), 2.15 (s, 3H, CH3-C2'), 2.34 (s, 3H, CH3-C4'), 
5.94 (s, 2H, C2H, C6H), 6.93 (dd, J = 0.7, 8.3 Hz, 1H, C6''H),  6.96 (s, 2H, C3'H, C5'H), 
6.98 (dd, J = 0.9, 7.8 Hz, 1H, C4''H), 7.49 (ddd, J = 1.8, 7.3, 8.3 Hz, 1H, C5''H), 8.08 (dd, J 
= 1.7, 7.8 Hz, 1H, C3''H). ¹³C NMR (CDCl3, 125 MHz): δ = 13.7 (CH3-C1, CH3-C7), 15.6 
(CH3-C3, CH3-C5), 19.8 (CH3-C2', CH3-C6'), 21.4 (CH3-C4'), 115.6 (C2''), 117.7 (C6''), 
119.8 (C4''), 122.0 (C2, C6), 129.1 (C5'), 129.3 (C3'), 130.2 (C3''), 131.1 (C1, C7), 131.3 
(C1'), 134.9 (C6'), 135.2 (C2'), 135.9 (C5''), 138.9 (C4'), 142.2 (C8), 143.1 (C9a, C9b), 
155.8 (C3, C5), 159.8 (C7''), 164.3 (C=O). HRMS (API-ES+): calcd. for C29H30BN2O3, 
(M+H)+: 465.2349, found: 465.2358. 
Synthesis of O-BODIPY 2b. Reaction of F-BODIPY 2 (40 mg, 0.129 mmol) with 
cyclopropane-1,1-dicarboxylic acid (22 mg, 0.169 mmol) following the general method for 
the synthesis of O-BODIPYs gave 2b (46 mg, 89%) as a dark-red solid, after flash 
chromatography purification (hexane/EtOAc 100:0 → 60:40). 
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Mp. 262-264 ºC. ¹H NMR (CDCl3, 500 MHz): δ = 1.99 (s, 4H, C3''H2, C4''H2), 2.11 (s, 6H, 
CH3-C2', CH3-C6'), 2.37 (s, 3H, CH3-C4'), 6.51 (dd, J = 2.0, 4.2 Hz, 2H, C2H, C6H), 6.75 
(s, 2H, C1H, C7H), 6.97 (s, 2H, C3'H, C5'H), 7.76 (s, 2H, C3H, C5H). ¹³C NMR (CDCl3, 
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125 MHz): δ = 20.2 (CH3-C2', CH3-C6'), 21.3 (CH3-C4'), 23.7 (C3'', C4''), 24.7 (C2''), 
119.4 (C2, C6), 128.4 (C3', C5'), 129.2 (C1'), 131.4 (C1, C7), 135.5 (C9a, C9b), 136.4 (C2', 
C6'), 139.4 (C4'), 144.3 (C3, C5), 148.8 (C8), 170.2 (2×C=O). HRMS (API-ES+): calcd. for 
C23H22BN2O4 (M+H)+: 401.1673, found 401.1665. 
Synthesis of O-BODIPY 2e. Reaction of F-BODIPY 2 (40 mg, 0.129 mmol) with 
cyclohexane-1,1-dicarboxylic acid (27 mg, 0.157 mmol) following the general method for 
the synthesis of O-BODIPYs gave 2e (34 mg, 60%) as a dark-red solid, after flash 
chromatography purification (hexane/EtOAc 100:0 → 80:20). 
N B NO O
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Mp. 244-246 ºC. ¹H NMR (CDCl3, 500 MHz): δ = 1.61 (m, 2H, C5''H2), 1.88 (m, 4H, 
C4''H2, C6''H2), 2.10 (s, 6H, CH3-C2', CH3-C6'), 2.20 (m, 4H, C3''H2, C7''H2), 2.36 (s, 3H, 
CH3-C4'), 6.47 (dd, J = 2.4, 3.9 Hz, 2H, C2H, C6H), 6.72 (d, J = 4.1 Hz, 2H, C1H, C7H), 
6.96 (s, 2H, C3'H, C5'H), 7.65 (s, 2H, C3H, C5H). ¹³C NMR (CDCl3, 125 MHz): δ = 20.2 
(CH3-C2', CH3-C6'), 21.3 (CH3-C4'), 21.7 (C4'', C6''), 24.9 (C5''), 33.4 (C3'', C7''), 50.8 
(C2''), 119.2 (C2, C6), 128.4 (C3', C5'), 129.3 (C1'), 131.4 (C1, C7), 135.6 (C9a, C9b), 
136.5 (C2', C6'), 139.3 (C4'), 144.1 (C3, C5), 148.6 (C8), 172.8 (2×C=O). HRMS (API-
ES+) calcd. for C26H28BN2O4 (M+H)+: 443.2142, found: 443.2141. 
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Synthesis of O-BODIPYs 2i and 2j. Reaction of F-BODIPY 2 (40 mg, 0.129 mmol) with 
chloroacetic acid (32 mg, 0.338 mmol) following the general method for the synthesis of 
O-BODIPYs gave 2i (6.1 mg, 12%) and 2j (39 mg, 66%) as dark-red and orange solids, 
respectively, after flash chromatography purification (hexane/EtOAc 100:0 → 80:20). 
N B NO F
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Mp. 36-39 ºC. 1H NMR (CDCl3, 500 MHz): δ = 2.09 (s, 3H, CH3-C2'), 2.18 (s, 3H, CH3-
C6'), 2.36 (s, 3H, CH3-C4'), 4.03 (s, 2H, C2''H2), 6.47 (dd, J = 1.9, 4.2 Hz, 2H, C6H, C2H), 
6.71 (d, J = 4.2 Hz, 2H, C1H, C7H), 6.95 (s, 1H, C3'H), 6,97(s, 1H, C5'H), 7.91 (s, 2H, 
C3H, C5H). 13C NMR (CDCl3, 125 MHz): δ = 20,12 (CH3-C2'), 20.14 (CH3-C6'), 21,3 
(CH3-C4'), 42,9 (C2''), 118,8 (C2, C6), 128,2 (C3'), 128,4 (C5'), 129,7 (C1'), 130,5 (C1, 
C7), 136,0 (C9a, C9b), 136,3 (C2'), 137,1 (C6'), 139.0 (C4'), 144,6 (C3, C5), 148,4 (C8), 
167,2 (C=O). HRMS (API-ES+): calcd. for C20H20BFClN2O2 (M+H)+: 385,1290, found: 
459.1036. 
3"
4"
N B NO O
1
2
3
6
5
7 8 9a9b
1'
2'
3'
4'
5'
6'
1"
2"
2j
O O
Cl Cl  
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Mp. 175-178 ºC. 1H NMR (CDCl3, 500 MHz): δ = 2.17 (s, 6H, CH3-C2', CH3-C6'), 2.36 (s, 
3H, CH3-C4'), 4.07 (s, 4H, C2''H2, C4''H2), 6.46 (dd, J = 2.0, 4.2 Hz, 2H, C6H, C2H), 6.72 
(d, J = 4.2 Hz, 2H, C1H, C7H), 6.96 (s, 2H, C3'H, C5'H), 7.90 (s, 2H, C3H, C5H). 13C 
NMR (CDCl3, 125 MHz): δ = 20,1 (CH3-C2', CH3-C6'), 21,3 (CH3-C4'), 42,8 (C2'', C4''), 
118,9 (C2, C6), 128,2 (C3', C5'), 129,7 (C1'), 130,6 (C1, C7), 136,5 (C9a, C9b), 136,9 (C2', 
C6'), 139.0 (C4'), 144,4 (C3, C5), 148,8 (C8), 167,2 (2×C=O). HRMS (API-ES+): calcd. for 
C22H22BCl2N2O4 (M+H)+: 459.1049, found: 459.1036. 
Synthesis of O-BODIPY 3a. Reaction of F-BODIPY 3 (40 mg, 0.087 mmol) with malonic 
acid (11 mg, 0.106 mmol) following the general method for the synthesis of O-BODIPYs 
gave 3a (31 mg, 68%) as a dark-red solid, after flash chromatography purification 
(hexane/EtOAc 100:0 → 80:20). 
N B N
Br
O O
O O
1
2
3
6
5
7 8 9a9b
1'
2'
3'
4'
5'
6'
1" 2" 3"
3a
 
Mp. 265-268 ºC. ¹H NMR (CDCl3, 500 MHz): δ = 0.95 (t, J = 7.6 Hz, 6H, CH3-CH2-C2, 
CH3-CH2-C6), 1.33 (s, 6H, CH3-C1, CH3-C7), 2.26 (s, 6H, CH3-C3, CH3-C5), 2.29 (c, J = 
7,6 Hz, 4H, CH3-CH2-C2, CH3-CH2-C6), 3.65 (s, 2H, C2''H2), 7.17 (d, J = 8.4 Hz, 2H, 
C2'H, C6'H), 7.67 (d, J = 8.4 Hz, 2H, C3'H, C5'H). ¹³C NMR (CDCl3, 125 MHz): δ = 12.4 
(CH3-C1, CH3-C7), 12.7 (CH3-C3, CH3-C5), 14.7 (CH3-CH2-C2, CH3-CH2-C6), 17.2 
(CH3-CH2-C2, CH3-CH2-C6), 38.0 (C2''), 123.6 (C4'), 130.1 (C2', C6'), 131.5 (C9a, C9b), 
132.8 (C3', C5'), 134.3 (C1'), 134.4 (C2, C6), 139.6 (C8), 140.2 (C1, C7), 153.3 (C3, C5), 
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166.7 (2×C=O). HRMS (API-ES+): calcd. for C26H29BBrN2O4 (M+H)+: 523.1404, found: 
523.1353. 
Synthesis of O-BODIPY 4a. Reaction of F-BODIPY 4 (40 mg, 0.138 mmol) with malonic 
acid (16 mg, 0.154 mmol) following the general method for the synthesis of O-BODIPYs 
gave 4a (36 mg, 74%) as a dark-red solid, after recrystallization of the crude evaporated 
reaction mixture from MeCN/EtOAc. 
N B NO O
O O
1
2
3
6
5
7 8 9a9b
1" 2" 3"
4a
 
Mp. 259-262 ºC. ¹H NMR (CDCl3, 500 MHz): δ = 2.28 (s, 6H, CH3-C3, CH3-C5), 2.43 (s, 
6H, CH3-C1, CH3-C7), 2.62 (s, 3H, CH3-C8), 3.59 (s, 2H, CH2-C2''), 6.09 (s, 2H, CH-C2, 
CH-C6). ¹³C NMR (CDCl3, 125 MHz): δ = 15.0 (CH3-C3, CH3-C5), 16.8 (CH3-C8), 17.7 
(CH3-C1, CH3-C7), 37.9 (C2''), 123.0 (C2, C6), 133.0 (C1, C7), 142.5 (C8), 142.8 (C9a, 
C9b), 152.8 (C3, C5), 166.6 (2×C=O). HRMS (API-ES+): calcd. for C17H20BN2O4 (M+H)+: 
327.1516, found: 327.1519. 
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3.	X-Ray	diffraction	structures	and	Table	S1	
		 	 a)																																				b)																
 
 
 
Compound 1a. (a) Two independent molecules in the crystal cell. (b) Crystal packing 
diagram. 
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   a)                                                b) 
 
 
 
 
 
 
 
c) 
 
 
 
 
 
 
 
 
 
Compound 1b. (a) Top view. (b) Side view. (c) Crystal packing diagram. 
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   a)                                                b) 
 
 
 
 
 
 
 
 
c) 
 
 
 
 
 
 
 
Compound 1c. (a) Top view. (b) Side view. (c) Crystal packing diagram. 
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   a)                                                b) 
 
 
 
 
 
 
 
 
 
c) 
 
 
 
 
 
 
 
 
Compound 1d. (a) Top view. (b) Side view. (c) Crystal packing diagram. 
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a)      b) 
 
 
 
 
 
 
 
 
c)  
 
 
 
 
 
 
 
 
 
Compound 1h. (a) Top view. (b) Side view. (c) Crystal packing diagram. 
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       a)       
 
 
 
 
 
 
c)  
 
 
 
 
 
 
 
 
 
 
 
Compound 1j. (a) Two independent molecules in the crystal cell. (b) Crystal packing 
diagram. 
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a)      b) 
 
 
 
 
 
 
 
c)  
 
 
 
 
 
 
 
 
 
Compound 2b. (a) Top view. (b) Side view. (c) Crystal packing diagram. 
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a)      b) 
 
 
 
 
 
 
 
 
c)  
 
 
 
 
 
 
 
 
Compound 2e. (a) Top view. (b) Side view. (c) Crystal packing diagram. 
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a)        b)  
 
 
 
 
 
c)  
 
 
 
 
 
 
 
 
Compound 4a. (a) Top view. (b) Side view. (c) Crystal packing diagram. 
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Table S1. Selected structural data for BODIPYs 1a-d, 1h, 2e, 2e, 2j, and 4a in the crystalline form. 
 1aa) 1b 1c 1d 1h 2b 2e 2ja) 4a 
dB—N (Å) 1.539(2) 
1.547(2) 
1.540(2) 
1.541(2) 
1.541(2) 
1.545(1) 
1.540(2) 
1.545(2) 
1.546(2) 
1.549(3) 
1.545(3) 
1.555(2) 
1.541(2) 
1.548(2) 
1.540(3) 
1.550(3) 
1.533(7) 
1.542(7) 
1.534(7) 
1.540(7) 
1.534(4) 
1.539(3) 
dB—O (Å) 1.467(2) 
1.474(2) 
1.467(2) 
1.477(2) 
1.467(1) 
1.474(1) 
1.469(2) 
1.475(1) 
1.466(3) 
1.479(2) 
1.452(3) 
1.477(2) 
1.461(2) 
1.461(2) 
1.412(4) 
1.521(7) 
1.474(6) 
1.477(6) 
1.474(6) 
1.479(6) 
1.464(3) 
1.482(3) 
Δ(BN2C3)meanb) 0.013 
0.048 
0.022 0.011 0.010 0.016 0.025 0.007 0.015 
0.018 
0.064 
Δ(BN2C3)maxc) 0.023 
0.085 
0.043 0.021 0.017 0.029 0.048 0.011 0.026 
0.033 
0.126 
<(NBN)d) 107.0(1)° 
107.5(1)° 
107.2(9)° 107.2(1)° 112.0(2)° 106.5(1)° 105.6(1)° 105.6(2)° 107.3(4)° 
106.1(4)° 
107.1(2) 
<(OBO)e) 113.2(1)° 
113.4(1)° 
113.1(9)° 112.3(1)° 106.7(2)° 113.6(2)° 114.0(1)° 109.8(4)° 101.9(4)° 
101.3(4)° 
113.4(2) 
<(C(O2)CC(O2))f) 117.9(1)° 
117.8(2)° 
120.0(9)° 115.9(1)° 115.1(2)° – 120.4(1)° 114.5(4)° – 117.4(2) 
<(BDP/BO2C3)g) 82.3° 
86.7° 
89.4° 85.5° 84.3° 89.2° 87.7° 88.2° 89.7°h) 
89.0°h) 
85.9° 
<(BDP/Mes)i) 88.4° 
88.1° 
79.6° 88.2° 87.7° 88.8° 70.0° 72.7° 80.7° 
74.4° 
– 
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a)Measurements	for	two	independent	molecules	in	the	unit	cell;	b)Mean	deviation	distance	for	the	atoms	of	the	BN2C3	central	ring	with	respect	to	the	least	squares	mean	plane	of	the	ring;	c)Maximum	deviation	distance	for	the	atoms	of	the	BN2C3	central	ring	with	respect	 to	 the	 least	 squares	mean	plane	of	 the	ring;	 d)N—B—N	bond	angle;	 e)O—B—O	bond	angle;	 f)O2C—C—CO2	bond	 angle;	 g)Dihedral	 angle	 between	 the	 least	 squares	 mean	 planes	 of	 the	 boradiazaindacene	 (C9BN2)	 system	 and	 the	
dioxaborinane (BO2C3) ring; h)Dihedral angle between	 the	 least	 squares	mean	plane	of	 the	boradiazaindacene	 (C9BN2)	 system	and	the	plane	of	the	O—B—O	group;	i)Dihedral	angle	between	the	least	squares	mean	plane	of	the	boradiazaindacene	(C9BN2)	system	and	the	mesityl	ring.		
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4.	1H	and	13C	NMR	spectra	of	the	new	dyes.	
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1H NMR (400 MHz, CDCl3) spectrum of compound 1a 
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13C NMR (100 MHz, CDCl3) spectrum of compound 1a 
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1H NMR (500 MHz, CDCl3) spectrum of compound 1b 
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13C NMR (125 MHz, CDCl3) spectrum of compound 1b 
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1H NMR (400 MHz, CDCl3) spectrum of compound 1c 
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13C NMR (100 MHz, CDCl3) spectrum of compound 1c 
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1H NMR (500 MHz, CDCl3) spectrum of compound 1d 
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13C NMR (125 MHz, CDCl3) spectrum of compound 1d 
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1H NMR (500 MHz, CDCl3) spectrum of compound 2b 
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13C NMR (125 MHz, CDCl3) spectrum of compound 2b 
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1H NMR (500 MHz, CDCl3) spectrum of compound 2e 
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13C NMR (125 MHz, CDCl3) spectrum of compound 2e 
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1H NMR (500 MHz, CDCl3) spectrum of compound 1g 
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13C NMR (125 MHz, CDCl3) spectrum of compound 1g 
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1HNMR (500 MHz, CDCl3) spectrum of compound 1h 
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13C NMR (125 MHz, CDCl3) spectrum of compound 1h 
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1H NMR (500 MHz, CDCl3) spectrum of compound 2i 
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13C NMR (125 MHz, CDCl3) spectrum of compound 2i 
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1H-NMR (500 MHz, CDCl3) spectrum of compound 2j 
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13C NMR (125 MHz, CDCl3) spectrum of compound 2j 
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1H NMR (500 MHz, CDCl3) spectrum of compound 3a 
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13C NMR (125 MHz, CDCl3) spectrum of compound 3a 
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1H NMR (500 MHz, CDCl3) spectrum of compound 4a 
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13C NMR (125 MHz, CDCl3) spectrum of compound 4a 
	 1	
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